Anti-PPAR gamma antibody
Specifications
| Product type: | Primary antibody |
| Antigen: | PPAR gamma |
| Immunogen: | Recombinant protein |
| Species immunized: | Rabbit |
| Isotype: | IgG |
| Applications: | Western Blot (1:800-1:2000) |
| Reactivity: | Mouse, Rat and Human |
| Clonality (clone number): | Monoclonal (JF101-4) |
| Form: | Liquid |
| Buffer: | Tris-HCl buffer (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
| Concentration: | 1mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | CIMT1 antibody |
| GLM1 antibody | |
| NR1C3 antibody | |
| Nuclear receptor subfamily 1 group C member 3 antibody | |
| OTTHUMP00000185032 antibody | |
| OTTHUMP00000185036 antibody | |
| Peroxisome proliferator activated nuclear receptor gamma variant 1 antibody | |
| Peroxisome proliferator activated receptor gamma 1 antibody | |
| Peroxisome Proliferator Activated Receptor gamma antibody | |
| Peroxisome proliferator-activated receptor gamma antibody | |
| PPAR gamma antibody | |
| PPAR-gamma antibody | |
| PPARG antibody | |
| PPARG_HUMAN antibody | |
| PPARG1 antibody | |
| PPARG2 antibody | |
| PPARgamma antibody |
Show More
Target information
Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated proinflammatory responses. Plays a role in the regulation of cardiovascular circadian rhythms by regulating the transcription of ARNTL/BMAL1 in the blood vessels (By similarity).By similarity4 Publications
(Microbial infection) Upon treatment with M.tuberculosis or its lipoprotein LpqH, phosphorylation of MAPK p38 and IL-6 production are modulated, probably via this protein.1 Publication
Provider
Erpantech Laboratory